| |
| |
|
| Insider
Information: |
Eastbourne Capital Management Llc/ca |
| Relationship: |
10% Owner |
| City: |
San Rafael |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
44,385,290 |
|
|
Indirect Shares
|
48,092,752 |
|
|
| Direct
Value |
$1,038,444,247 |
|
|
|
Indirect Value
|
$560,822,041 |
|
|
| Total
Shares |
92,478,042 |
|
|
| Total
Value |
$1,599,266,288 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-09-29 |
3,230,204 |
2007-12-31 |
10,901,174 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
11,850,000 |
2010-05-10 |
1,532,709 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2009-09-17 |
13,346,120 |
2007-12-31 |
20,220,126 |
Premium* |
|
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-09-16 |
10,299,755 |
2009-03-11 |
15,438,743 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2010-03-04 |
5,659,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
88 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-03-28 |
4 |
B |
$28.10 |
$3,342,017 |
D/D |
118,933 |
20,575,442 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-02-12 |
4 |
B |
$0.44 |
$56,135 |
D/D |
126,202 |
13,447,578 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-21 |
4 |
S |
$0.99 |
$125,285 |
D/D |
(126,653) |
13,202,538 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-29 |
4 |
S |
$0.81 |
$116,379 |
D/D |
(143,068) |
11,897,385 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2008-12-29 |
4 |
B |
$0.30 |
$48,176 |
D/D |
146,571 |
11,621,571 |
2.37 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-14 |
4 |
B |
$29.37 |
$4,336,235 |
D/D |
147,308 |
21,477,750 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-06-06 |
4 |
B |
$29.91 |
$4,489,000 |
D/D |
150,000 |
23,226,562 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-03 |
4 |
B |
$30.50 |
$4,738,918 |
D/D |
155,000 |
20,730,442 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-12 |
4 |
S |
$5.04 |
$947,392 |
D/D |
(185,780) |
8,457,000 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-09 |
4 |
B |
$30.05 |
$6,271,435 |
D/D |
208,700 |
21,039,142 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-28 |
4 |
S |
$0.84 |
$179,389 |
D/D |
(213,547) |
12,040,453 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-04-06 |
4 |
S |
$3.93 |
$849,360 |
D/D |
(215,803) |
9,175,874 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-05-07 |
4 |
B |
$27.88 |
$6,976,615 |
D/D |
250,000 |
23,076,562 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-08 |
4 |
S |
$5.33 |
$1,531,115 |
D/D |
(286,467) |
8,889,407 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-11 |
4 |
B |
$29.80 |
$8,723,362 |
D/D |
291,300 |
21,330,442 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-01-22 |
4 |
B |
$0.45 |
$157,911 |
D/D |
322,809 |
13,140,017 |
2.45 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
10% Owner |
– – • |
2009-11-11 |
4 |
S |
$1.41 |
$473,092 |
D/D |
(333,950) |
13,890,188 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-30 |
4 |
B |
$27.72 |
$9,886,393 |
D/D |
356,652 |
22,826,562 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-07-07 |
4 |
S |
$4.54 |
$1,686,436 |
D/D |
(368,000) |
8,060,897 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2008-12-30 |
4 |
B |
$0.34 |
$146,783 |
D/D |
414,814 |
12,036,385 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2008-12-31 |
4 |
B |
$0.36 |
$178,766 |
D/D |
485,690 |
12,522,075 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-04-02 |
4 |
S |
$4.22 |
$2,538,280 |
D/D |
(600,534) |
9,475,340 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-21 |
4 |
B |
$28.52 |
$25,521,703 |
D/D |
894,000 |
22,469,910 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-22 |
4 |
S |
$0.86 |
$826,948 |
D/D |
(948,538) |
12,254,000 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-03-02 |
4 |
S |
$3.40 |
$3,577,507 |
D/D |
(1,000,000) |
10,075,874 |
0 |
- |
|
88 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
